Compounds > pirfenidone
Page last updated: 2024-08-23

pirfenidone and Colitis

pirfenidone has been researched along with Colitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G; Deng, Y; Gu, G; Guo, K; Hu, Q; Li, G; Li, J; Li, R; Li, Y; Ren, J; Wang, G; Wu, L1
Chilvers, ER; Fiddler, CA; Miremadi, A; Parfrey, H; Simler, N1

Other Studies

2 other study(ies) available for pirfenidone and Colitis

ArticleYear
Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Biochemical pharmacology, 2016, Oct-01, Volume: 117

    Topics: Administration, Oral; Administration, Rectal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Proliferation; Cell Survival; Colitis; Collagen; Colon; Disease Models, Animal; Female; Fibrosis; Gastrointestinal Agents; Humans; Intestinal Mucosa; Mice, Inbred C57BL; Pyridones; Random Allocation; Signal Transduction; Specific Pathogen-Free Organisms; Transforming Growth Factor beta

2016
Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
    Annals of the American Thoracic Society, 2016, Volume: 13, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones

2016